Attached files
| file | filename |
|---|---|
| EX-99.1 - Merck & Co., Inc. | ex99.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 6, 2017
Merck & Co., Inc.
(Exact Name of Registrant as Specified in Its Charter)
New Jersey
(State or Other Jurisdiction of Incorporation)
|
1-6571
|
|
22-1918501
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
2000 Galloping Hill Road, Kenilworth, NJ
|
|
07033
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant's Telephone Number, Including Area Code (908) 740-4000
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§204.12b-2 of this chapter)
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
Attached as Exhibit 99.1 and incorporated by reference herein is a press release, dated November 6, 2017, issued by Merck & Co., Inc.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit 99.1
|
|
Press release issued November 6, 2017, regarding tender offer launch.
|
EXHIBIT INDEX
|
Exhibit
|
|
|
|
Number
|
|
Description
|
|
|
|
|
|
99.1
|
|
Press release issued November 6, 2017, regarding tender offer launch.
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Merck & Co., Inc. | |||
|
Date: November 6, 2017
|
By:
|
/s/ Karen L. Mealey | |
|
KAREN L. MEALEY
|
|||
|
Assistant Secretary
|
|||